SG10201706265PA - Novel compounds and compositions for targeting cancer stem cells - Google Patents

Novel compounds and compositions for targeting cancer stem cells

Info

Publication number: SG10201706265PA
Authority: SG; Singapore
Prior art keywords: compositions; stem cells; novel compounds; cancer stem; targeting cancer
Prior art date: 2010-03-19

Application number

SG10201706265PA

Other languages

English (en)

Inventor

David Leggett

Chiang Jia Li

Youzhi Li

Wei Li

Original Assignee

Boston Biomedical Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-03-19

Filing date

2011-03-21

Publication date

2017-08-30

2011-03-21 Application filed by Boston Biomedical Inc filed Critical Boston Biomedical Inc

2017-08-30 Publication of SG10201706265PA publication Critical patent/SG10201706265PA/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/92—Naphthofurans; Hydrogenated naphthofurans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Immunology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Pregnancy & Childbirth (AREA)
Rheumatology (AREA)
Gynecology & Obstetrics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Hematology (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)

SG10201706265PA 2010-03-19 2011-03-21 Novel compounds and compositions for targeting cancer stem cells SG10201706265PA (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US31589010P	2010-03-19	2010-03-19
US31588610P	2010-03-19	2010-03-19
US32581410P	2010-04-19	2010-04-19

Publications (1)

Publication Number	Publication Date
SG10201706265PA true SG10201706265PA (en)	2017-08-30

Family

ID=50940329

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
SG10201502079VA SG10201502079VA (en)	2010-03-19	2011-03-21	Novel compounds and compositions for targeting cancer stem cells
SG10201704745UA SG10201704745UA (en)	2010-03-19	2011-03-21	Novel compounds and compositions for targeting cancer stem cells
SG10201706265PA SG10201706265PA (en)	2010-03-19	2011-03-21	Novel compounds and compositions for targeting cancer stem cells

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
SG10201502079VA SG10201502079VA (en)	2010-03-19	2011-03-21	Novel compounds and compositions for targeting cancer stem cells
SG10201704745UA SG10201704745UA (en)	2010-03-19	2011-03-21	Novel compounds and compositions for targeting cancer stem cells

Country Status (11)

Country	Link
EP (2)	EP3295796A1 (fr)
JP (11)	JP5993390B2 (fr)
CN (3)	CN107311969B (fr)
CA (3)	CA2993363A1 (fr)
DK (1)	DK3108750T3 (fr)
ES (1)	ES2689928T3 (fr)
HU (1)	HUE066482T2 (fr)
NZ (2)	NZ701237A (fr)
PT (1)	PT2547205T (fr)
RU (2)	RU2015142279A (fr)
SG (3)	SG10201502079VA (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2736564A1 (fr)	2007-09-10	2009-03-19	Boston Biomedical, Inc.	Compositions et procedes nouveaux pour le traitement du cancer
RU2015142279A (ru) *	2010-03-19	2018-12-28	Бостон Байомедикал, Инк.	Новые соединения и композиции для нацеливания на злокачественные стволовые клетки
JP2013522326A (ja) *	2010-03-19	2013-06-13	ボストンバイオメディカル，インコーポレイテッド	がん幹細胞を標的とするための新規の方法
SG11201508358RA (en)	2013-04-09	2015-11-27	Boston Biomedical Inc	2-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancer
US20180140572A1 (en) *	2015-06-03	2018-05-24	Boston Biomedical, Inc.	Compositions comprising a cancer stemness inhibitor and an immunotherapeutic agent for use in treating cancer
GB201515391D0 (en) *	2015-08-28	2015-10-14	Amazentis Sa	Compositions
GB201515387D0 (en) *	2015-08-28	2015-10-14	Amazentis Sa	Compositions
JP6751658B2 (ja)	2016-11-15	2020-09-09	クラリオン株式会社	音声認識装置、音声認識システム
WO2018102427A1 (fr)	2016-11-29	2018-06-07	Boston Biomedical, Inc.	Dérivés de naphthofurane, préparation et procédés d'utilisation associés
JP2020520923A (ja)	2017-05-17	2020-07-16	ボストンバイオメディカル，インコーポレイテッド	がんを処置するための方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS61205257A (ja) *	1985-03-08	1986-09-11	Ishihara Sangyo Kaisha Ltd	ベンゾイルウレア系化合物、その製法及びそれを含有する抗ガン剤
EP0945131A1 (fr) *	1998-03-27	1999-09-29	Boehringer Ingelheim Pharma KG	Suspension perorale de medicaments
AU2736400A (en) *	1999-01-27	2000-08-18	University Of South Florida	Inhibition of stat3 signal transduction for human cancer therapy
US20060142271A1 (en) *	2002-09-17	2006-06-29	Klaus Muller	Novel lapacho compounds and methods of use thereof
TWI335913B (en) *	2002-11-15	2011-01-11	Vertex Pharma	Diaminotriazoles useful as inhibitors of protein kinases
EP1849830B1 (fr) *	2005-01-28	2012-02-29	Takeda Pharmaceutical Company Limited	Composition finement divisee contenant un substance peu hydrosoluble
JP2006290871A (ja) *	2005-03-16	2006-10-26	Taheebo Japan Kk	抗癌性を示す化合物およびその中間体ならびにそれらの製造方法
US20080255193A1 (en) *	2005-09-30	2008-10-16	Jeffrey Brum	Pharmaceutical Composition
EP1860126A1 (fr) *	2006-05-26	2007-11-28	INEOS Manufacturing Belgium NV	Poudre polyoléfinique
CA2736564A1 (fr) *	2007-09-10	2009-03-19	Boston Biomedical, Inc.	Compositions et procedes nouveaux pour le traitement du cancer
JP5719770B2 (ja) *	2008-07-08	2015-05-20	ベータ・ファーマ・インコーポレイテッドＢｅｔａＰｈａｒｍａ，Ｉｎｃ．	塩酸イコチニブ、合成物、結晶学的形態、併用薬及びその用途
JP2013522326A (ja) *	2010-03-19	2013-06-13	ボストンバイオメディカル，インコーポレイテッド	がん幹細胞を標的とするための新規の方法
RU2015142279A (ru) *	2010-03-19	2018-12-28	Бостон Байомедикал, Инк.	Новые соединения и композиции для нацеливания на злокачественные стволовые клетки
KR101908208B1 (ko) *	2010-03-19	2018-10-15	보스톤 바이오메디칼, 인크.	암 줄기 세포를 표적화하는 신규 화합물 및 조성물

2011
- 2011-03-21 RU RU2015142279A patent/RU2015142279A/ru not_active Application Discontinuation
- 2011-03-21 CA CA2993363A patent/CA2993363A1/fr not_active Abandoned
- 2011-03-21 SG SG10201502079VA patent/SG10201502079VA/en unknown
- 2011-03-21 EP EP17196754.0A patent/EP3295796A1/fr active Pending
- 2011-03-21 ES ES16182813.2T patent/ES2689928T3/es active Active
- 2011-03-21 CN CN201710613672.3A patent/CN107311969B/zh active Active
- 2011-03-21 RU RU2016123004A patent/RU2657750C1/ru active
- 2011-03-21 NZ NZ701237A patent/NZ701237A/en not_active IP Right Cessation
- 2011-03-21 PT PT117571356T patent/PT2547205T/pt unknown
- 2011-03-21 DK DK16182813.2T patent/DK3108750T3/en active
- 2011-03-21 CA CA2959951A patent/CA2959951A1/fr not_active Abandoned
- 2011-03-21 SG SG10201704745UA patent/SG10201704745UA/en unknown
- 2011-03-21 NZ NZ712826A patent/NZ712826A/en unknown
- 2011-03-21 EP EP16182813.2A patent/EP3108750B1/fr active Active
- 2011-03-21 CN CN201710134235.3A patent/CN106860443A/zh active Pending
- 2011-03-21 CN CN201410101861.9A patent/CN104016951B/zh active Active
- 2011-03-21 SG SG10201706265PA patent/SG10201706265PA/en unknown
- 2011-03-21 HU HUE11757135A patent/HUE066482T2/hu unknown
- 2011-03-21 CA CA2959931A patent/CA2959931A1/fr not_active Abandoned
2014
- 2014-03-03 JP JP2014040225A patent/JP5993390B2/ja not_active Expired - Fee Related
- 2014-03-03 JP JP2014040226A patent/JP2014098049A/ja not_active Withdrawn
- 2014-03-03 JP JP2014040227A patent/JP2014098050A/ja not_active Withdrawn
2015
- 2015-02-25 JP JP2015035285A patent/JP2015098489A/ja active Pending
- 2015-09-11 JP JP2015179115A patent/JP6246169B2/ja not_active Expired - Fee Related
2016
- 2016-09-30 JP JP2016194176A patent/JP2016222723A/ja not_active Withdrawn
2017
- 2017-10-13 JP JP2017199380A patent/JP2018002744A/ja not_active Withdrawn
2018
- 2018-04-20 JP JP2018081329A patent/JP2018115209A/ja not_active Withdrawn
2020
- 2020-01-31 JP JP2020014705A patent/JP2020063308A/ja not_active Withdrawn
- 2020-05-08 JP JP2020082479A patent/JP2020114888A/ja active Pending
2021
- 2021-12-06 JP JP2021197732A patent/JP2022020002A/ja active Pending

Also Published As

Publication number	Publication date
JP2014098048A (ja)	2014-05-29
CN107311969B (zh)	2022-01-28
JP2014098050A (ja)	2014-05-29
JP6246169B2 (ja)	2017-12-13
CN104016951A (zh)	2014-09-03
JP2016222723A (ja)	2016-12-28
HUE066482T2 (hu)	2024-08-28
DK3108750T3 (en)	2018-10-22
JP2022020002A (ja)	2022-01-27
SG10201704745UA (en)	2017-07-28
NZ712826A (en)	2017-03-31
NZ701237A (en)	2016-04-29
CA2959951A1 (fr)	2011-09-22
RU2657750C1 (ru)	2018-06-15
SG10201502079VA (en)	2015-06-29
RU2015142279A3 (fr)	2019-02-26
EP3108750A1 (fr)	2016-12-28
JP2015232037A (ja)	2015-12-24
JP2014098049A (ja)	2014-05-29
ES2689928T3 (es)	2018-11-16
JP2018115209A (ja)	2018-07-26
EP3108750B1 (fr)	2018-07-04
CA2993363A1 (fr)	2011-09-22
PT2547205T (pt)	2024-05-27
JP2018002744A (ja)	2018-01-11
RU2015142279A (ru)	2018-12-28
JP2020114888A (ja)	2020-07-30
CN104016951B (zh)	2016-07-13
JP2015098489A (ja)	2015-05-28
CN106860443A (zh)	2017-06-20
JP2020063308A (ja)	2020-04-23
CN107311969A (zh)	2017-11-03
JP5993390B2 (ja)	2016-09-14
CA2959931A1 (fr)	2011-09-22
EP3295796A1 (fr)	2018-03-21

Publication	Publication Date	Title
LT2547205T (lt)	2024-06-10	Nauji tikslinio poveikio vėžio kamieninėms ląstelėms būdai
HRP20171343T1 (hr)	2017-12-29	Mješavine
GB201002983D0 (en)	2010-04-07	Nutritinal composition
GB201009549D0 (en)	2010-07-21	Compositions
SG10201706265PA (en)	2017-08-30	Novel compounds and compositions for targeting cancer stem cells
GB201019297D0 (en)	2010-12-29	Improved compositions
GB201009546D0 (en)	2010-07-21	Compositions
GB201010954D0 (en)	2010-08-11	Compositions
EP2625231A4 (fr)	2014-04-16	Compositions imprimables à l'encre
GB201002861D0 (en)	2010-04-07	Compositions
WO2011116344A9 (fr)	2012-01-05	Ciblage de cellules souches cancéreuses
SI2534242T1 (sl)	2016-08-31	Izboljšan sestavek za inhibicijo tumorske celične proliferacije
GB201017048D0 (en)	2010-11-24	Composition
IL214545A0 (en)	2011-09-27	Compositions and methods for visualizing and eliminating cancer stem cells
IL225952A0 (en)	2013-07-31	preparations@rokkhot
GB201014591D0 (en)	2010-10-13	Compositions
GB201007790D0 (en)	2010-06-23	Compositions
GB201005927D0 (en)	2010-05-26	Improved composition
GB201004717D0 (en)	2010-05-05	Composition
EP2575743A4 (fr)	2015-04-08	Compositions antisudorales
PL2545016T3 (pl)	2015-10-30	Kompozycja zawierająca fosforan hemipotasowy
GB201019606D0 (en)	2010-12-29	Compositions
GB201008043D0 (en)	2010-06-30	Compositions
GB201006182D0 (en)	2010-06-02	Composition
GB201006175D0 (en)	2010-06-02	Composition